Hallucinations in Parkinson’s disease: new insights into mechanisms and treatments

Hallucinations in Parkinson’s disease: new insights into mechanisms and treatments

Bibliographic Details
Main Authors:	Weil, Rimona, Reeves, Suzanne
Format:	Article
Language:	English
Published:	Whitehouse Publishing 2020-01-01
Series:	Advances in Clinical Neuroscience & Rehabilitation
Online Access:	https://www.acnr.co.uk/2020/07/hallucinations-in-parkinsons/

Similar Items

Changes in dynamic transitions between integrated and segregated states underlie visual hallucinations in Parkinson’s disease
by: Angeliki Zarkali, et al.
Published: (2022-09-01)

Hiccups, Hypersalivation, Hallucinations in Parkinson’s Disease: New Insights, Mechanisms, Pathophysiology, and Management
by: Vinod Metta, et al.
Published: (2023-04-01)

Behavioral impulsivity and hallucinations : insights from Parkinson's disease
by: Ashourian, Paymon
Published: (2012)

Sleep-related hallucinations in patients with Parkinson's disease.
by: Tomoko Komagamine, et al.
Published: (2022-01-01)

Risk Factors in Developing Hallucinations in Parkinson’s Disease
by: Gülçin Benbir, et al.
Published: (2006-02-01)

Frequency and Determinants of Olfactory Hallucinations in Parkinson’s Disease Patients
by: Paolo Solla, et al.
Published: (2021-06-01)

Visual hallucinations and inferior longitudinal fasciculus in Parkinson's disease
by: Natsuko Yuki, et al.
Published: (2020-12-01)

Testing an aetiological model of visual hallucinations in Parkinson's disease
by: Gallagher, D, et al.
Published: (2011)

Mapping brain structural differences and neuroreceptor correlates in Parkinson's disease visual hallucinations
by: Vignando, M, et al.
Published: (2022)

Parkinson's Disease With Visual Hallucinations Is Associated With Epileptiform Activity on EEG
by: Adam Fry, et al.
Published: (2022-01-01)

Phantosmia in Parkinson’s Disease: A Systematic Review of the Phenomenology of Olfactory Hallucinations
by: Tommaso Ercoli, et al.
Published: (2023-12-01)

Cannabis Dopaminergic Effects Induce Hallucinations in a Patient with Parkinson’s Disease
by: Katie Pizzolato, et al.
Published: (2021-10-01)

Characteristics of sleep structure in Parkinson's disease patients with hallucinations based on polysomnography
by: Ruxin Gu, et al.
Published: (2022-11-01)

A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease
by: Nation Daniel, et al.
Published: (2008-06-01)

Mescal and mechanisms of hallucinations /
by: 465756 Kluver, Heinrich
Published: (1966)

Visual Hallucination, Visual Evoked Potentials and Cognitive Dysfunction in Idiopathic Parkinson’s Disease
by: Tuba Aydemir Özcan, et al.
Published: (2011-09-01)

Visual Hallucination, Visual Evoked Potentials and Cognitive Dysfunction in Idiopathic Parkinson’s Disease
by: Tuba Aydemir Özcan, et al.
Published: (2011-09-01)

Aberrant gray matter volume and functional connectivity in Parkinson’s disease with minor hallucination
by: Min Zhong, et al.
Published: (2022-09-01)

Cholinesterase inhibitors for Parkinson’s disease-related visual hallucinations unresponsive to atypical antipsychotics
by: Tomasz Sobow
Published: (2007-03-01)

Exploring Bottom-Up Visual Processing and Visual Hallucinations in Parkinson's Disease With Dementia
by: Nicholas Murphy, et al.
Published: (2021-01-01)

Neural correlates of early cognitive dysfunction in Parkinson's disease
by: Rimona S. Weil, et al.
Published: (2019-05-01)

Damaged fiber tracts of the nucleus basalis of Meynert in Parkinson's disease patients with visual hallucinations.
by: Hepp, D, et al.
Published: (2017)

Numerosity estimation of virtual humans as a digital-robotic marker for hallucinations in Parkinson’s disease
by: Louis Albert, et al.
Published: (2024-03-01)

Global brain analysis of minor hallucinations in Parkinson’s disease using EEG and MRI data
by: Chuan Liu, et al.
Published: (2024-01-01)

Visual hallucinations in parkinson’s disease: Experience from a portuguese level 3 hospital
by: J. Quarenta, et al.
Published: (2021-04-01)

Minor hallucinations in Parkinson’s disease with probable rapid eye movement sleep behavior disorder
by: Yinyin Jiang, et al.
Published: (2023-08-01)

New Insights into Immune-Mediated Mechanisms in Parkinson’s Disease
by: Jolene Su Yi Tan, et al.
Published: (2020-12-01)

Organisational and neuromodulatory underpinnings of structural-functional connectivity decoupling in patients with Parkinson’s disease
by: Angeliki Zarkali, et al.
Published: (2021-01-01)

Current concepts and controversies in the pathogenesis of Parkinson’s disease dementia and Dementia with Lewy Bodies [version 1; referees: 2 approved]
by: Rimona S. Weil, et al.
Published: (2017-08-01)

Clinical features of minor hallucinations in different phenotypes of Parkinson’s disease: A cross-sectional study
by: Yaxi Wang, et al.
Published: (2023-03-01)

Feasibility of a Web-Based Survey of Hallucinations and Assessment of Visual Function in Patients With Parkinson’s Disease
by: Jackson, Mary Lou, et al.
Published: (2014-01-01)

Fatigue is associated with the onset of hallucinations in patients with Parkinson's disease: A 3-year prospective study
by: Masanori Ikeda, et al.
Published: (2016-09-01)

Differences and Changes in Cerebellar Functional Connectivity of Parkinson’s Patients with Visual Hallucinations
by: Liangcheng Qu, et al.
Published: (2023-10-01)

Mechanisms of auditory verbal hallucination in schizophrenia
by: Raymond eCho, et al.
Published: (2013-11-01)

Association between Visual Evoked Potential and Disease Severity, Disease Duration and Visual Hallucination in Patients with Idiopathic Parkinsonism
by: Mahnaz Talebi, et al.
Published: (2014-11-01)

Pulvinar quantitative susceptibility mapping predicts visual hallucinations post‐deep brain stimulation in Parkinson's disease
by: Keita Matsuura, et al.
Published: (2023-11-01)

Musical hallucinations: review of treatment effects
by: Jan eCoebergh, et al.
Published: (2015-06-01)

Tiapride for the treatment of auditory hallucinations in schizophrenia
by: Sagar Karia, et al.
Published: (2013-01-01)

Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐up
by: Tom J. M. vanMierlo, et al.
Published: (2021-08-01)

Subclinical elevation of plasma C-reactive protein and illusions/hallucinations in subjects with Parkinson's disease: case-control study.
by: Hideyuki Sawada, et al.
Published: (2014-01-01)